Company / Income Tax per Share
AVADEL PHARMACEUTICALS PLC Income Tax per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.00
FY2024
5-year range
-$0.27 / $0.43
FY2020-FY2024
Trend
+58.5%
vs FY2023
Sector context
#174 of 201
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's income tax per share of $-0.00 is lower than 87% of companies in the Health Care sector (FY2024). Income Tax per Share has fluctuated over the past 10 years, ranging from $-0.48 in FY2018 to $0.82 in FY2015.
Based on SEC 10-K filings.
-0.00 in FY2024.
Improved from $0.43 to $-0.00 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 201This company -$0.00 Sector average $1.35
▼
-100.2% below sector average
Key checks
Key Insights
- In FY2024, income tax per share increased 58.5% year-over-year.
- Ranks #174 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2015.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.00 | +58.5% |
| FY2023 | -$0.01 | -101.4% |
| FY2022 | $0.43 | +260.3% |
| FY2021 | -$0.27 | -22.6% |
| FY2020 | -$0.22 | -53.9% |
| FY2019 | -$0.14 | +70.1% |
| FY2018 | -$0.48 | -182.1% |
| FY2017 | $0.58 | -23.7% |
| FY2016 | $0.77 | -7.1% |
| FY2015 | $0.82 | +4729.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026